+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Abscess Drug"

Abscess - Pipeline Insight, 2024 - Product Thumbnail Image

Abscess - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Epidural Abscess Treatment Global Market Report 2024 - Product Thumbnail Image

Epidural Abscess Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Abscess - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Abscess - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Abscess Drug market is a subset of the Infectious Diseases Drugs market, which focuses on the treatment of infections caused by bacteria, viruses, fungi, and parasites. Abscess drugs are used to treat localized infections that are characterized by a collection of pus, which is caused by the body's immune response to the infection. These drugs are typically administered orally or intravenously, depending on the severity of the infection. Commonly used abscess drugs include antibiotics, antifungals, antivirals, and antiparasitics. The Abscess Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, and Johnson & Johnson. Show Less Read more